HUANG JAMES purchased 13.3% of their position (37.20K shares) of CASI PHARMACEUTICALS, INC (DE) on the open market
Open‑market purchase worth $139.0K — a moderate purchase. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 9/2/2022ACC: 0000899243-22-030336
+37.20K
Net shares
Net buyer
$139.0K
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
37.20K acquired
Non-Derivative Transactions3
Common Stock
Indirect
Shares
+24.98K
Price / share
$3.75
Trade value
$93.53K
% of position
9.0%
8/31/2022
278.75K→303.72K
Common Stock
Indirect
Shares
+11.82K
Price / share
$3.72
Trade value
$44.01K
% of position
3.9%
9/1/2022
303.72K→315.54K
Common Stock
Indirect
Shares
+400.00
Price / share
$3.74
Trade value
$1.50K
% of position
0.1%
9/2/2022
315.54K→315.94K
Total
Net shares
+37.20K
Net value
$139.04K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 8/31/2022 | P · Purchase | +24.98K | $3.75 | $93.53K | 9.0% | 278.75K | 303.72K |
| Common Stock Indirect | 9/1/2022 | P · Purchase | +11.82K | $3.72 | $44.01K | 3.9% | 303.72K | 315.54K |
| Common Stock Indirect | 9/2/2022 | P · Purchase | +400.00 | $3.74 | $1.50K | 0.1% | 315.54K | 315.94K |
| Total | +37.20K | $139.04K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned191.00
Total
191.00 direct191.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 191.00 | Direct |
| Total | 191.00 | 191.00 direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported